論文診断の市場規模、シェア、成長分析：製品別、デバイスタイプ別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

論文診断市場規模は2023年に151億8,000万米ドルと評価され、2024年の163億8,000万米ドルから2032年には300億9,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは7.9％で成長する見通しです。

論文診断市場は、特に遠隔地や資源が限られた地域でのポイントオブケア検査において、利用しやすく経済的な選択肢として大きな成長を遂げています。紙ベースの基材を利用することで、これらのデバイスはマラリア、HIV、糖尿病を含む様々な疾患の迅速かつ正確な医療診断を可能にし、最小限の設備と技術的専門知識を必要とします。製造コストが低く、廃棄が簡単で、環境モニタリングや食品安全などの用途に汎用性があるなどの利点が、需要を牽引しています。医療サービスが行き届いていない地域での分散型ヘルスケアソリューションの推進が、その人気をさらに高めています。しかし、結果の信頼性の確保、安定性の維持、分析対象物の検出範囲の拡大といった課題は依然として残っています。継続的な調査、製造方法の改善、ヘルスケアプロバイダーと業界利害関係者の協力が、この市場を前進させると予想されます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 特許分析

論文診断市場規模：製品別& CAGR（2025-2032）

• 市場概要
• ディップスティック
• ラテラルフローアッセイ
• 紙ベースのマイクロ流体

論文診断市場規模：デバイスタイプ別& CAGR（2025-2032）

• 市場概要
• 監視デバイス
• 診断デバイス

論文診断市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 環境モニタリング
• 臨床診断
• 食品品質検査

論文診断市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 在宅ヘルスケア
• 介護付き生活ヘルスケア施設
• 病院と診療所

論文診断市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Abbott Laboratories（USA）
• Bio-Rad Laboratories（USA）
• Siemens Healthineers（Germany）
• Abcam Plc（UK）
• Chembio Diagnostic Systems Inc.（USA）
• ACON Laboratories Inc.（USA）
• FFEI（UK）
• ARKRAY Inc.（Japan）
• Creative Diagnostics（USA）
• OraSure Technologies, Inc.（USA）
• Quidel Corporation（USA）
• Thermo Fisher Scientific Inc.（USA）
• Danaher Corporation（USA）
• Becton, Dickinson and Company（BD）（USA）
• Roche Diagnostics（Switzerland）
• PerkinElmer Inc.（USA）
• Sysmex Corporation（Japan）
• bioMerieux SA（France）
• Hologic, Inc.（USA）
• Merck KGaA（Germany）

結論と提言

Paper Diagnostics Market size was valued at USD 15.18 billion in 2023 and is poised to grow from USD 16.38 billion in 2024 to USD 30.09 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The paper diagnostics market is witnessing significant growth as an accessible and economical option for point-of-care testing, especially in remote and resource-limited areas. By utilizing paper-based substrates, these devices enable swift and accurate medical diagnoses for various diseases, including malaria, HIV, and diabetes, while requiring minimal equipment and technical expertise. Their advantages, such as low production costs, easy disposal, and versatility in applications like environmental monitoring and food safety, are driving demand. The push for decentralized healthcare solutions in underserved regions further enhances their popularity. However, challenges like ensuring result reliability, maintaining stability, and broadening analyte detection persist. Continued research, improved manufacturing methods, and collaborations among healthcare providers and industry stakeholders are expected to propel this market forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Paper Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Paper Diagnostics Market Segments Analysis

Global Paper Diagnostics Market is segmented by Product, Device Type, Application, End-User and region. Based on Product, the market is segmented into Dipsticks, Lateral Flow Assays and Paper-Based Microfluidics. Based on Device Type, the market is segmented into Monitoring Devices and Diagnostic Devices. Based on Application, the market is segmented into Environmental Monitoring, Clinical Diagnostics and Food Quality Testing. Based on End-User, the market is segmented into Home Healthcare, Assisted Living Healthcare Facilities and Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Paper Diagnostics Market

The Paper Diagnostics market is driven by the increasing demand for point-of-care testing solutions that are both rapid and cost-effective. These diagnostic tools facilitate immediate diagnosis and treatment, making them particularly valuable in resource-limited or rural areas lacking access to conventional laboratory facilities. By providing a convenient and efficient means of conducting tests on-site, paper diagnostics help bridge the gap in healthcare availability, ensuring timely interventions and improved patient outcomes. The ability to obtain results swiftly and affordably positions this market as a crucial component in the broader healthcare landscape, addressing the needs of underserved populations effectively.

Restraints in the Paper Diagnostics Market

The dependence of healthcare systems on conventional diagnostic methods poses a significant challenge for the paper diagnostics market, as it hinders the integration or substitution of these innovations in certain contexts. Many established healthcare institutions are accustomed to using traditional diagnostic techniques, which can limit their willingness to adopt newer paper-based solutions. This reliance on established practices creates a barrier to the acceptance and implementation of paper diagnostics, ultimately restraining market growth and reducing the potential for innovation in the field. As a result, overcoming this resistance remains a crucial factor for the advancement of paper diagnostics.

Market Trends of the Paper Diagnostics Market

The Paper Diagnostics market is experiencing a notable upswing, propelled by the rise of Point-of-Care Testing (POCT). This trend is largely fueled by the growing demand for rapid and convenient diagnostic solutions that align with the decentralized healthcare model. Paper-based diagnostics offer a crucial advantage by providing immediate results without the need for complex machinery or specialized personnel, making them ideal for various healthcare settings, including remote and resource-limited areas. As healthcare providers increasingly prioritize efficiency and accessibility, the Paper Diagnostics market is expected to flourish, catering to the evolving needs of patients and healthcare professionals alike.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Paper Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Dipsticks
• Lateral Flow Assays
• Paper-Based Microfluidics

Global Paper Diagnostics Market Size by Device Type & CAGR (2025-2032)

• Market Overview
• Monitoring Devices
• Diagnostic Devices

Global Paper Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Environmental Monitoring
• Clinical Diagnostics
• Food Quality Testing

Global Paper Diagnostics Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Home Healthcare
• Assisted Living Healthcare Facilities
• Hospitals and Clinics

Global Paper Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Device Type, Application, End-User)
  • US
  • Canada
• Europe (Product, Device Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Device Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Device Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Device Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chembio Diagnostic Systems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACON Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FFEI (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations